Two of three antigens does not close a gap. A meningococcal shot and a Tdap booster, with the HPV series left unfinished, earn the same measure credit as no visit at all — zero. That all-or-nothing math is identical for the toddler who is one dose of PCV short and the adolescent who never came back for a second HPV dose, and it is why the most reliable fix is not a better reminder card but a single immunization gap closure workflow that treats every childhood and adolescent vaccine as one connected job.
Three Measures, Three Deadlines, One Panel
Most practices run immunizations as three separate efforts: baby shots, the adolescent visit, and a standalone push on HPV. Each has its own reminder list, its own champion in the office, and its own moment of the year when someone realizes the numbers are behind. Three campaigns mean three chances to lose the thread.
The measures underneath them behave identically. Childhood Immunization Status (CIS), Immunizations for Adolescents (IMA), and the HPV series that lives inside IMA are all HEDIS gaps that close only when every required antigen is captured before a hard age deadline. [1][2] Miss one dose, or miss the birthday, and the whole measure reads as open. Run them as three disconnected campaigns and you multiply the ways to miss. Run them as one workflow and the discipline that closes a two-year-old’s chart is the same discipline that closes a twelve-year-old’s.
What Each Measure Actually Requires
CIS Combo 10 — Every Antigen by the Second Birthday
CIS credits a child who has completed the full Combo 10 series — DTaP, IPV, MMR, HiB, HepB, VZV, PCV, HepA, rotavirus, and influenza — by the second birthday. [1] Doses given after that birthday do not count, and a chart note that a “child is up to date” without the dated records behind it does not meet the criteria. The measure rewards timing and evidence, not intention.
IMA Combo 2 — Meningococcal, Tdap, and a Complete HPV Series by 13
IMA credits an adolescent who, by the thirteenth birthday, has received a meningococcal vaccine, a Tdap booster, and a complete HPV series. [2] The first two are familiar school-entry shots; the third is where the measure is usually lost, because HPV takes more than one visit and the second dose rarely gets scheduled with the same urgency as the first.
HPV — Start at 9 to Turn Three Doses Into Two
The single most powerful move on the adolescent gap is timing the first HPV dose early. Started between ages 9 and 14, HPV is a two-dose series, with the second dose 6 to 12 months later; started at 15 or older, it becomes a three-dose series. [3] Beginning at 9 — well before the routine 11-to-12-year-old visit — turns three chances to miss into two and gives the series room to finish before the IMA deadline.
Running the Three as One Workflow
None of this is a knowledge problem. Every practice knows which shots are due. The failure mode is operational: the eligible patient who is in the room for something else and leaves still due. A cross-measure workflow is built to close exactly that gap, and it runs on three habits.
Work One Panel, Not Three Lists
Start from a single prioritized view of who is due rather than three separate reminder lists. In CareEmpower®, the Worklist surfaces every patient with an open care opportunity — the toddler due for PCV and the adolescent due for a second HPV dose appear in the same queue, sorted by urgency rather than by whichever campaign someone happens to be running that month. [4] One panel means one place to look, and no measure quietly falling behind while attention is elsewhere.
Prepare the Chart Before the Patient Arrives
The capture moment is the visit itself, so the work has to be done before it starts. A pre-visit chart summary that lists every open immunization — across CIS, IMA, and HPV — puts the full picture in front of the clinician at the point of care instead of surfacing it in a claims report months later. [4] The back-to-school 11-to-12-year-old visit is the richest of these moments: meningococcal and Tdap are common school-entry requirements, which makes it the natural place to start or advance the HPV series in the same encounter.
Capture at Every Touch, and Count to Closure
Treat every well visit, sick visit, and chronic-care touch as an immunization opportunity, and track each measure down to the antigen. CareEmpower counts CIS and IMA at the dose level and moves a gap to closed only when all required antigens are in — ten for CIS, three for IMA — so a partially vaccinated child stays visible until the series is genuinely complete. [4] That is the operational answer to the two-of-three problem: the workflow does not let a near-miss read as a win.
These measures also sit inside the Prevention and Screenings pillar of ECIP, our activity-based payment program, so the same routine that closes the clinical gap also earns credit. Which immunization measures are in scope varies by state, so it is worth confirming your market’s set with your Practice Performance Manager.
The Payoff Compounds
The clinical case for getting this right outlasts the measure year. HPV vaccination prevents more than 90 percent of the cancers HPV causes when the series is completed before exposure. [5] Every finished series today is a cervical, oropharyngeal, or anal cancer that never appears a generation from now — and, further downstream, a cleaner cervical-cancer screening denominator as those adolescents become adults. The two-year-old whose Combo 10 is finished on time and the twelve-year-old whose HPV series is complete are the same win, banked years apart.
Build the Immunization Gap Closure Workflow Once
An immunization gap closure workflow is not three campaigns run more carefully; it is one routine run once. When the panel, the pre-visit prep, and the count-to-closure habit are shared across CIS, IMA, and HPV, the child who is one dose short does not disappear between visits, and the adolescent who started HPV at nine finishes it with time to spare. Build the workflow once, and every eligible patient in your panel gets the full protection the schedule was designed to give.
References
[1] National Committee for Quality Assurance. “Childhood Immunization Status (CIS),” HEDIS Measurement Year 2025. https://www.ncqa.org/hedis/measures/childhood-immunization-status/
[2] National Committee for Quality Assurance. “Immunizations for Adolescents (IMA),” HEDIS Measurement Year 2025. https://www.ncqa.org/hedis/measures/immunizations-for-adolescents/
[3] Centers for Disease Control and Prevention. “HPV Vaccine Recommendations and Dosing Schedule.” https://www.cdc.gov/vaccines/vpd/hpv/hcp/recommendations.html
[4] Equality Health. CareEmpower Provider User Guide, 2026.
[5] Centers for Disease Control and Prevention. “HPV Vaccine Effectiveness and Cancer Prevention.” https://www.cdc.gov/hpv/
